ClinicalTrials.Veeva

Menu

Statin With Palliative Therapy for HCC

T

Taipei Medical University

Status

Terminated

Conditions

HCC

Treatments

Drug: Statin

Study type

Interventional

Funder types

Other

Identifiers

NCT02785874
N201603038

Details and patient eligibility

About

Statin is a preventive medicine for hepatitis B and hepatitis C which decreases the risk turning into liver cancer,however, the investigators also discovered that patients taking Statin live longer than patients who didn't take Statin in the incidence of liver cancer death cases.

Full description

Most liver cancer patients did not accept the cure as the main objective of the treatment after diagnosis because they choose alternative therapies palliative based, such as hepatic arterial chemoembolization, chemotherapy and radiation therapy.

Statin is a preventive medicine for hepatitis B and hepatitis C which decreases the risk turning into liver cancer, yet the clinical effect for Statin is still unknown.

In a previous study of 20,220 liver cancer patients in health care database, the investigators discovered that patients taking Statin live longer than patients who didn't take Statin in the incidence of liver cancer death cases.

This study is a continuation of previous health insurance database studies for clinical trials to verify whether Statin could prolong disease-free survival role for palliative treatment of liver cancer.

Enrollment

4 patients

Sex

All

Ages

20 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. >20 years old.
  2. BCLC stage B , stage C and stage D

Exclusion criteria

  1. Cancer diagnosis before HCC was confirmed and incurable.
  2. <20 years old, > 90years old.
  3. Patients who are judged to be ineligible for study entry by the investigator or subinvestigator

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

4 participants in 2 patient groups

Statin(Crestor) taken
Experimental group
Description:
Subjects take Statin(Crestor) 10mg per day for a- year
Treatment:
Drug: Statin
non Statin(Crestor) taken
No Intervention group
Description:
non Statin(Crestor) taken as a reference for experimental group.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems